Skip to main content
Clinical Trials/NCT01650220
NCT01650220
Terminated
N/A

Cardiovascular Risk Markers in Veterans With PTSD

INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium1 site in 1 country13 target enrollmentApril 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Enrollment
13
Locations
1
Primary Endpoint
Recruitment methods feasibility
Status
Terminated
Last Updated
13 years ago

Overview

Brief Summary

This is an observational study designed to determine whether veterans with PTSD have a higher risk of heart disease than those without PTSD. Cardiovascular risk will be assessed by interview and review of medical records, carotid artery ultrasound, and blood tests measuring markers of inflammation. Study participation is approximately 6 months. The eligible study population is veterans of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), age 28 through 38 years.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
January 2013
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • OEF/OIF veterans at the VASDHS
  • Between 28 and 38 years of age
  • Willing to complete structured diagnostic interview for PTSD, CIMT ultrasound and blood test
  • Willing to have a review of their medical records
  • Able to give informed consent
  • Have a negative urine pregnancy test, if a woman of child-bearing age

Exclusion Criteria

  • Do not meet inclusion criteria
  • History of schizophrenia, other neurocognitive illness (including severe TBI by INTRuST criteria)) or active alcohol and/or drug abuse determined by chart review, interview or AUDIT-C score
  • Inability to complete study tests within 18 months of study start
  • Pregnancy

Outcomes

Primary Outcomes

Recruitment methods feasibility

Time Frame: 12 months

Comparison of the number of participants per month recruited from medical providers (with/without PTSD) vs. response to recruitment fliers (with/without PTSD) in the first 12 months of the study. Selection bias to be determined by looking at differences in age and co-morbid illnesses.

Completion of structured diagnostic interview within 2hrs.

Time Frame: 12 months

Completion of Clinician Assessed PTSD Scale (CAPS), Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), Patient Health Questionnaire-9 (PHQ-9), Pittsburgh Sleep Quality Index (PSQI), INTRuST Uniformed Data Set, and Family History of heart disease, within 2hrs.

Ability to schedule Carotid Intima-Media Thickness (CIMT) ultrasound in the Vascular Lab at VA San Diego Healthcare Systems, within 4 months of enrollment

Time Frame: 18months

Determining whether the Vascular Lab has the capacity for a larger clinical study will be informative in planning larger prospective studies.

Time from CIMT completion to completion of clinical read.

Time Frame: 18months

Rate of clinical read will help in determining adequate staffing requirements for a larger study.

Completion of serum lab measurements.

Time Frame: 18months

Secondary Outcomes

  • Carotid Intimal Medial Thickness (CIMT) measurement(Within 4 months of subject recruitment)
  • Cardiovascular Disease Biomarkers(Within 6 months of subject recruitment)

Study Sites (1)

Loading locations...

Similar Trials